Data/hora: 13/06/2024 23:39:23

Provedor de dados: | 17
País: | United Kingdom
Título: | Improving cellular cancer vaccines
Autores: | Petr Lokhov.
Data: | 2010-04-20
Ano: | 2010
Palavras-chave: | Biotechnology; Cancer; Pharmacology.
Resumo: | Immunization with cancer cells is of great demand in anti-cancer therapy. However, current cellular vaccines are inefficient and there are questions regarding their overall safety. We report a simple and straightforward approach for improving of cellular cancer vaccines. Through treatment of cancer cell cultures with purified protease, it is possible to make preparations of cell-surface antigens that are free of intracellular content and contain two orders-of-magnitude less protein than the whole lysate of an equivalent number of cancer cells. Despite this difference in total protein content, protease-generated preparations stimulate anti-cancer responses from immune cells better those stimulated with cancer cells themselves. The composition of collected cell-surface antigens, prior to vaccination, can be directly compared with antigenic profile of target cancer cells by the proteomic footprinting. Any contaminates (cell parasites, viruses, toxins, prions, etc.) are easily separated from antigens by means of ultrafiltration. Thus, current cellular vaccines may be improved by replacing whole cancer cells with their isolated cell-surface antigens. Vaccines prepared in this manner are potentially more qualified, purer, and safer.
Tipo: | Manuscript

Identificador:

http://precedings.nature.com/documents/4356/version/1

oai:nature.com:10101/npre.2010.4356.1

http://hdl.handle.net/10101/npre.2010.4356.1

Fonte: | Nature Precedings
Fonte: | Creative Commons Attribution 3.0 License